BetaPublic beta

Spending
Lobbying
Coming soon: Congress, Stocks

Spending
- Overview
- Agencies
- Programs
- Recipients
- Awards
Lobbying
Congress
Stocks

About Privacy Terms

© 2026 Adaptrex, LLC

About
Privacy
Terms

© 2026 Adaptrex, LLC

Spending
Lobbying
Coming soon: Congress, Stocks

Overview Firms Clients Revolving Door Stands Out

LD-2 disclosure · 2nd Quarter - Report

TEVA PHARMACEUTICALS USA INC.

via KEVIN MCGUINESS PLLC

2nd Quarter (Apr 1 - June 30) · 2013Posted Jul 22, 2013Filing document ↗LDA record ↗

Income$38Kfee reported

Client

Name: TEVA PHARMACEUTICALS USA INC.
Description: Manufacture of pharmaceutical products
Location: Pennsylvania · United States of America

Registrant

Firm: KEVIN MCGUINESS PLLC
Description: Lobbyist/Attorney
Location: Washington, District of Columbia, United States of America

Lobbying activities

1 issue

Copyright/Patent/Trademark
S. 214, the Preserve Access to Affordable Generics Act
LobbyistsKEVIN MCGUINESS
TargetedSENATE · HOUSE OF REPRESENTATIVES

Source

Source · Senate Office of Public Records — Lobbying Disclosure Act filings ↗.

Coverage gaps · LD-2 reports a single dollar figure per quarter on ONE basis — income (a fee) or expenses (self-filed spend), never both — so this page never combines them into one "spend" number.

TEVA PHARMACEUTICALS USA INC. — Lobbying — Receipts Report